RR001 / EIR Biotherapies - LARVOL DELTA

SNIPER: Phase I/IIa Study: RR001 Administered Following Chemotherapy Cycles for Patients With Locally Advanced Pancreatic Carcinoma (clinicaltrials.gov) - P1/2 | N=9 | Recruiting | Sponsor: EIR Biotherapies s.r.l. | Trial completion date: Jan 2027 ➔ Jan 2028 | Trial primary completion date: Jul 2026 ➔ Jul 2027

Trial completion date • Trial primary completion date • Oncology • Pancreatic Adenocarcinoma • Pancreatic Cancer • Pancreatic Ductal Adenocarcinoma • Solid Tumor